Allied Healthcare Group has taken a major step towards commercialisation of its cardiovascular tissue patch in the U.S. with the lodging of its Premarket Notification 510(k) submission. The U.S. is the largest global market for regenerative medicine and gaining approval gives Allied commercial entry.













